Livzon Pharmaceutical Group (SZSE:000513) Accounts Payable & Accrued Expense : ¥5,506 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Accounts Payable & Accrued Expense?

Livzon Pharmaceutical Group's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥5,612 Mil) to Dec. 2023 (¥5,380 Mil) but then increased from Dec. 2023 (¥5,380 Mil) to Mar. 2024 (¥5,506 Mil).

Livzon Pharmaceutical Group's annual accounts payable & accrued expense increased from Dec. 2021 (¥4,691 Mil) to Dec. 2022 (¥5,439 Mil) but then declined from Dec. 2022 (¥5,439 Mil) to Dec. 2023 (¥5,380 Mil).

Livzon Pharmaceutical Group Accounts Payable & Accrued Expense Historical Data

The historical data trend for Livzon Pharmaceutical Group's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Accounts Payable & Accrued Expense Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3,781.04

4,412.69

4,691.31

5,438.82

5,379.59

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,388.87	6,436.58	5,612.32	5,379.59	5,506.40

Livzon Pharmaceutical Group Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Executives

Xu Guo Xiang	Directors, executives
Tang Yang Gang	Directors, executives
Yang Liang	Secretary Dong
Si Yan Xia	Executives
Zhou Peng	Executives
Huang Yu Xuan	Executives
Huang Hua Min	Supervisors
Yang Dai Hong	Executives
Wang Wu Ping	Executives

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines